On the stock market since 1991, it operates in the world of health and science. It has 380 employees. Now — the numbers.
This is an established company with proven profits.
An average decline of 4% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
The gap is $282.1M. In times of high interest rates, a gap like that can squeeze a company.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are growing slowly.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
The net profit margin is 22% — still a thick cushion, though costs have been eating into it lately.
It pays out $2.05 per share each year — regular cash for whoever holds the stock.
This stock swings about 2.1 times as much as the market average. Big rallies — and big drops — can both happen fast.
Over the last 3 years, sales fell about 7% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
On our five-subject report card, TVTY sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: TVTY is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.